LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | Trametinib | 3.33 | uM | LJP5 | 3 | P20 | 72 | hr | 1235 | 1347 | 4929 | 0.2733 | 0.0441 |
MDA-MB-231 | Trametinib | 10 | uM | LJP5 | 1 | P19 | 72 | hr | 1235 | 1148 | 4474 | 0.2566 | -0.0390 |
MDA-MB-231 | Trametinib | 10 | uM | LJP5 | 2 | P19 | 72 | hr | 1235 | 1240 | 4578 | 0.2708 | 0.0017 |
MDA-MB-231 | Trametinib | 10 | uM | LJP5 | 3 | P19 | 72 | hr | 1235 | 1469 | 4929 | 0.2980 | 0.0904 |
MDA-MB-231 | Omipalisib | 0.04 | uM | LJP6 | 1 | N06 | 72 | hr | 1235 | 1857 | 4355 | 0.4263 | 0.2511 |
MDA-MB-231 | Omipalisib | 0.04 | uM | LJP6 | 2 | N06 | 72 | hr | 1235 | 1952 | 4277 | 0.4564 | 0.2907 |
MDA-MB-231 | Omipalisib | 0.04 | uM | LJP6 | 3 | N06 | 72 | hr | 1235 | 2201 | 4583 | 0.4802 | 0.3569 |
MDA-MB-231 | Omipalisib | 0.12 | uM | LJP6 | 1 | N05 | 72 | hr | 1235 | 1585 | 4355 | 0.3639 | 0.1467 |
MDA-MB-231 | Omipalisib | 0.12 | uM | LJP6 | 2 | N05 | 72 | hr | 1235 | 1446 | 4277 | 0.3381 | 0.0916 |
MDA-MB-231 | Omipalisib | 0.12 | uM | LJP6 | 3 | N05 | 72 | hr | 1235 | 1525 | 4583 | 0.3327 | 0.1176 |
MDA-MB-231 | Omipalisib | 0.37 | uM | LJP6 | 1 | N04 | 72 | hr | 1235 | 1141 | 4355 | 0.2619 | -0.0430 |
MDA-MB-231 | Omipalisib | 0.37 | uM | LJP6 | 2 | N04 | 72 | hr | 1235 | 1118 | 4277 | 0.2614 | -0.0545 |
MDA-MB-231 | Omipalisib | 0.37 | uM | LJP6 | 3 | N04 | 72 | hr | 1235 | 1208 | 4583 | 0.2636 | -0.0120 |
MDA-MB-231 | Omipalisib | 1.11 | uM | LJP6 | 1 | N03 | 72 | hr | 1235 | 947 | 4355 | 0.2174 | -0.1363 |
MDA-MB-231 | Omipalisib | 1.11 | uM | LJP6 | 2 | N03 | 72 | hr | 1235 | 917 | 4277 | 0.2144 | -0.1535 |
MDA-MB-231 | Omipalisib | 1.11 | uM | LJP6 | 3 | N03 | 72 | hr | 1235 | 1035 | 4583 | 0.2258 | -0.0896 |
MDA-MB-231 | Omipalisib | 3.33 | uM | LJP6 | 1 | N02 | 72 | hr | 1235 | 805 | 4355 | 0.1848 | -0.2102 |
MDA-MB-231 | Omipalisib | 3.33 | uM | LJP6 | 2 | N02 | 72 | hr | 1235 | 826 | 4277 | 0.1931 | -0.2015 |
MDA-MB-231 | Omipalisib | 3.33 | uM | LJP6 | 3 | N02 | 72 | hr | 1235 | 842 | 4583 | 0.1837 | -0.1837 |
MDA-MB-231 | Omipalisib | 10 | uM | LJP6 | 1 | N01 | 72 | hr | 1235 | 701 | 4355 | 0.1609 | -0.2681 |
MDA-MB-231 | Omipalisib | 10 | uM | LJP6 | 2 | N01 | 72 | hr | 1235 | 687 | 4277 | 0.1606 | -0.2796 |
MDA-MB-231 | Omipalisib | 10 | uM | LJP6 | 3 | N01 | 72 | hr | 1235 | 781 | 4583 | 0.1704 | -0.2156 |
MDA-MB-231 | Buparlisib | 0.04 | uM | LJP5 | 1 | H06 | 72 | hr | 1235 | 4624 | 4474 | 1.0334 | 1.0357 |
MDA-MB-231 | Buparlisib | 0.04 | uM | LJP5 | 2 | H06 | 72 | hr | 1235 | 4615 | 4578 | 1.0080 | 1.0084 |
MDA-MB-231 | Buparlisib | 0.04 | uM | LJP5 | 3 | H06 | 72 | hr | 1235 | 4661 | 4929 | 0.9456 | 0.9447 |